Hsbc Holdings PLC Raises Stock Position in Stryker Corporation $SYK

Hsbc Holdings PLC boosted its position in shares of Stryker Corporation (NYSE:SYK) by 3.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 688,707 shares of the medical technology company’s stock after acquiring an additional 24,670 shares during the period. Hsbc Holdings PLC’s holdings in Stryker were worth $216,432,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Sankala Group LLC purchased a new stake in shares of Stryker during the 4th quarter valued at $26,000. Godfrey Financial Associates Inc. acquired a new position in Stryker during the 4th quarter valued at about $26,000. United Financial Planning Group LLC purchased a new stake in Stryker in the third quarter valued at about $27,000. Atlas Capital Advisors Inc. purchased a new stake in Stryker in the fourth quarter valued at about $27,000. Finally, Gables Capital Management Inc. acquired a new stake in Stryker in the second quarter worth about $25,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Stryker news, insider Dylan Crotty sold 441 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Debra King sold 826 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 351,267 shares of company stock valued at $118,197,701 over the last ninety days. Company insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

SYK has been the topic of a number of research analyst reports. BMO Capital Markets began coverage on Stryker in a research note on Wednesday, July 8th. They set an “outperform” rating and a $369.00 price target on the stock. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Wolfe Research downgraded shares of Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. Piper Sandler cut their price target on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating on the stock in a research note on Friday, July 31st. Finally, Royal Bank Of Canada decreased their price target on shares of Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $386.28.

Stryker Stock Down 0.1%

Shares of SYK stock opened at $302.92 on Monday. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.37. The firm has a market capitalization of $116.19 billion, a PE ratio of 31.39, a P/E/G ratio of 1.90 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The stock’s 50-day simple moving average is $328.84 and its 200-day simple moving average is $329.48.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the prior year, the firm earned $3.13 earnings per share. Stryker’s revenue for the quarter was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts expect that Stryker Corporation will post 15.03 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.